Emerging evidence suggests that Aβ may be necessary but not sufficient as a cause of AD, and Aβ’s major pathological effects, many of them tau-dependent, culminate years later in neurodegeneration [5,6]. This evidence concerns the gene MAPT and Alzheimer disease.